- This event has passed.
Presenter(s): Thomas Penders, MD, Walter B Jones Ctr; East Carolina University; Cornel Stanciu, MD, MRO, Director of Addiction Services at New Hampshire Hospital and Assistant Professor of Psychiatry at Dartmouth’s Geisel School of Medicine
Target audience: This activity was developed to meet the needs of primary care physicians and specialty care physicians.
Cost: No fee.
Webinar description: This Q and A webinar will further discuss Drs. Penders and Stanciu’s webinar from 11/28/18, “Kratom, A Substance of Increasing Concern.” It will allow participants of the webinar to pose questions to both presenters and they will address questions that were not covered during the original training session.
Note: Completion of the archived webinar Kratom, A Substance of Increasing Concern is recommended prior to the follow-up session.
- Recognize the salient aspects of Kratom’s background, psychoactive effects, and its pharmacological action
- Review the state of knowledge about the impact of Kratom on mental health and its potentially dangerous adverse effects
- Identify and manage Kratom withdrawal as well as provide maintenance treatment
How to obtain your Certificate of Completion:
Thank you for viewing our archived webinar. In order to document your participation in the training, please follow the steps below to obtain your Certificate of Completion.
- View the recorded webinar and return to the web page that listed the webinar recording link. By viewing the full presentation it will unlock and allow you to proceed to the evaluation.
- Click “Evaluation” and answer the questions to the best of your ability. Upon completion, you will receive a verification code on the last page of the survey.
- Copy the verification code located on the last page of the survey and paste it into its designated component on the original web page to claim your certificate.
- If you have any questions or you do not receive your certificate, please email or call (855) 227-2776.
Note: This archive webinar is not designated for AMA PRA Category 1 Credit™.